Use of methylation status of mint loci and tumor-related genes as a marker for melanoma and breast cancer
Номер патента: EP2238265A2
Опубликовано: 13-10-2010
Автор(ы): Anneke Van Hoesel, Atsushi Tanemura, Dave S.B. Hoon
Принадлежит: JOHN WAYNE CANCER INSTITUTE
Опубликовано: 13-10-2010
Автор(ы): Anneke Van Hoesel, Atsushi Tanemura, Dave S.B. Hoon
Принадлежит: JOHN WAYNE CANCER INSTITUTE
Реферат: The invention relates to a method of detecting melanoma or breast cancer using DNA methylation in MINT17, MINT31, or the promoter region of WIF1, TFPI2, RASSF1A, SOCS1, GATA4, or RARβ2 as a biomarker. Also disclosed are methods of using the biomarker for determining the cancer status and predicting the outcome of the cancer.
Use of methylation status of mint loci and tumor-related genes as a marker for melanoma and breast cancer
Номер патента: EP2238265A4. Автор: Atsushi Tanemura,Anneke Van Hoesel,Dave S B Hoon. Владелец: JOHN WAYNE CANCER INSTITUTE. Дата публикации: 2012-01-18.